Melusin, a muscle-specific integrin β1-interacting protein, is required to prevent cardiac failure in response to chronic pressure overload

Nature Medicine

Volumn 9, Issue 1, 2003, Pages 68-75

  Brancaccio, Mara ^a   Fratta, Luigi ^b   Notte, Antonella ^b   Hirsch, Emilio ^a,c   Poulet, Roberta ^b   Guazzone, Simona ^a   De Acetis, Marika ^a   Vecchione, Carmine ^b   Marino, Gennaro ^b   Altruda, Fiorella ^a,c   Silengo, Lorenzo ^a,c   Tarone, Guido ^a,c   Lembo, Giuseppe ^b,d  

^a UNIVERSITY OF TURIN   (Italy)

^b IRCCS NEUROMED   (Italy)

^c MOLINETTE HOSPITAL   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; BETA1 INTEGRIN; GLYCOGEN SYNTHASE KINASE 3BETA; MELUSIN; MUSCLE PROTEIN; PHENYLEPHRINE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL KINETICS; CONTROLLED STUDY; DISEASE COURSE; ENZYME PHOSPHORYLATION; GENE INACTIVATION; HEART DILATATION; HEART FAILURE; HEART FUNCTION; HEART HEMODYNAMICS; HEART MUSCLE CONTRACTILE FORCE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE OVERLOAD; HEMODYNAMIC MONITORING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

ANGIOTENSIN II; ANIMALS; ANTIGENS, CD29; AORTIC COARCTATION; BIOMECHANICS; CARDIAC OUTPUT, LOW; CARDIOMEGALY; CARRIER PROTEINS; CYTOSKELETAL PROTEINS; ECHOCARDIOGRAPHY; FEMALE; GENE SILENCING; HEART VENTRICLES; HEMODYNAMIC PROCESSES; MALE; MICE; MICE, KNOCKOUT; MUSCLE PROTEINS; MUSCLE, SKELETAL; MYOCARDIUM; PHENYLEPHRINE; SIGNAL TRANSDUCTION; STRESS, MECHANICAL; VASOCONSTRICTOR AGENTS;

ANIMALIA;

EID: 0037236642     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm805     Document Type: Article

References (42)

1. Chien, K.R. Stress pathways and heart failure. Cell 98, 555-558 (1999).
2. Chien, K.R. & Olson, E.N. Converging pathways and principles in heart development and disease: CV@CSH. Cell 110, 153-162 (2002).
3. Sadoshima, J. & Izumo, S. The cellular and molecular response of cardiac myocytes to mechanical stress. Annu. Rev. Physiol. 59, 551-571 (1997).
4. Ruwhof, C. & van der Laarse, A. Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways. Cardiovasc. Res. 47, 23-37 (2000).
5. Sadoshima, J. & Izumo, S. Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac myocytes: potential involvement of an autocrine/paracrine mechanism. EMBO J. 12, 1681-1692 (1993).
6. Schultz Jel, J. et al. TGF-β1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II. J. Clin. Invest. 109, 787-796 (2002).
7. MacLellan, W.R. & Schneider, M.D. Genetic dissection of cardiac growth control pathways. Annu. Rev. Physiol. 62, 289-319 (2000).
8. Yamazaki, T. et al. Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy. J. Biol. Chem. 271, 3221-3228 (1996).
9. Wettschureck, N. et al. Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Gαq/Gα11 in cardiomyocytes. Nat. Med. 7, 1236-1240 (2001).
10. Akhter, S.A. et al. Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. Science 280, 574-577 (1998).
11. Dorn, G.W. 2nd & Brown, J. H. Gq signaling in cardiac adaptation and maladaptation. Trends Cordiovosc. Med. 9, 26-34 (1999).
12. Wakasaki, H. et al. Targeted overexpression of protein kinase C β2 isoform in myocardium causes cardiomyopathy. Proc. Natl. Acad. Sci. USA 94, 9320-9325 (1997).
13. Sugden, P.H. & Clerk, A. Cellular mechanisms of cardiac hypertrophy. J. Mol. Med. 76, 725-746 (1998).
14. Hunter, J.J. & Chien, K.R. Signaling pathways for cardiac hypertrophy and failure. N. Engl. J. Med. 341, 1276-1283 (1999).
15. Harada, K. et al. Pressure overload induces cardiac hypertrophy in angiotensin II type 1A receptor knockout mice. Circulation 97, 1952-1959 (1998).
16. Vecchione, C. et al. Cardiovascular influences of α1b-adrenergic receptor defect in mice. Circulation 105, 1700-1707 (2002).
17. Schwartz, M.A., Schaller, M.D. & Ginsberg, M.H. Integrins: emerging paradigms of signal transduction. Annu. Rev. Cell Dev. Biol. 11, 549-599 (1995).
18. Fassler, R. et al. Differentiation and integrity of cardiac muscle cells are impaired in the absence of β1 integrin. J. Cell Sci. 109, 2989-2899 (1996).
19. Keller, R.S. et al. Disruption of integrin function in the murine myocardium leads to perinatal lethality, fibrosis, and abnormal cardiac performance. Am. J. Pathol. 158, 1079-1090 (2001).
20. Shai, S.Y. et al. Cardiac myocyte-specific excision of the β1 integrin gene results in myocardial fibrosis and cardiac failure. Circ. Res. 90, 458-464 (2002).
21. Brancaccio, M. et al. Melusin is a new muscle-specific interactor for β1 integrin cytoplasmic domain. J. Biol. Chem. 274, 29282-29288 (1999).
22. Hirota, H. et al. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell 97, 189-198 (1999).
23. Badorff, C. et al. Fas receptor signaling inhibits glycogen synthase kinase 3β and induces cardiac hypertrophy following pressure overload. J. Clin. Invest. 109, 373-381 (2002).
24. Rockman, H.A., Koch, W.J. & Lefkowitz, R.J. Seven-transmembrane-spanning receptors and heart function. Nature 415, 206-212 (2002).
25. Haq, S. et al. Glycogen synthase kinase-3β is a negative regulator of cardiomyocyte hypertrophy. J. Cell Biol. 151, 117-130 (2000).
26. Morisco, C. et al. Glycogen synthase kinase 3β regulates GATA4 in cardiac myocytes. J. Biol. Chem. 276, 28586-28597 (2001).
27. Antos, C.L. et al. Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo. Proc. Natl. Acad. Sci. USA 99, 907-912 (2002).
28. Cohen, P. & Frame, S. The renaissance of GSK3. Nat. Rev. Mol. Cell Biol. 2, 769-776 (2001).
29. Persad, S. et al. Regulation of protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase: critical roles for kinase activity and amino acids arginine 211 and serine 343. J. Biol. Chem. 276, 27462-27469 (2001).
30. Ivaska, J. et al. Integrin α2β1 mediates isoform-specific activation of p38 and up-regulation of collagen gene transcription by a mechanism involving the α2 cytoplasmic tail. J. Cell Biol. 147, 401-416 (1999).
31. Norton, G.R. et al. Heart failure in pressure overload hypertrophy. The relative roles of ventricular remodeling and myocardial dysfunction. J. Am. Coll. Cardiol. 39, 664-671 (2002).
32. Esposito, G. et al. Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress. Circulation 105, 85-92 (2002).
33. Wang, Y. Signal transduction in cardiac hypertrophy - dissecting compensatory versus pathological pathways utilizing a transgenic approach. Curr. Opin. Pharmacol. 1, 134-140 (2001).
34. MacLellan, W.R. Advances in the molecular mechanisms of heart failure. Curr. Opin. Cardiol. 15, 128-135 (2000).
35. Nicol, R.L. et al. Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy. EMBO J. 20, 2757-2767 (2001).
36. Wollert, K.C. et al. The cardiac Fas (APO-1/CD95) Receptor/Fas ligand system relation to diastolic wall stress in volume-overload hypertrophy in vivo and activation of the transcription factor AP-1 in cardiac myocytes. Circulation 101, 1172-1178 (2000).
37. Schwartz, M.A. & Ginsberg, M.H. Networks and crosstalk: integrin signalling spreads. Nat. Cell Biol. 4, E65-E658 (2002).
38. Lembo, G. et al. Elevated blood pressure and enhanced myocardial contractility in mice with severe IGF-1 deficiency. J. Clin. Invest. 98, 2648-2655 (1996).
39. Belkin, A.M. et al. Muscle β1D integrin reinforces the cytoskeleton-matrix link: modulation of integrin adhesive function by alternative splicing. J. Cell Biol. 139, 1583-1595 (1997).
40. Brancaccio, M. et al. Differential onset of expression of α7 and β1D integrins during mouse heart and skeletal muscle development. Cell Adhes. Commun. 5, 193-205 (1998).
41. Condorelli, G. et al. Increased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic genes bax and bcl-2 during left ventricular adaptations to chronic pressure overload in the rat. Circulation 99, 3071-3078 (1999).
42. Cabodi, S. et al. A PKC-β/Fyn-dependent pathway leading to keratinocyte growth arrest and differentiation. Mol. Cell 6, 1121-1129 (2000).